Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2020 / Cilt: 30 - Sayı: 2

Comparison of HLA and Non-HLA Antibodies Regarding to Rejection Pattern of the Kidney Transplantation

Böbrek Transplantasyonunda Rejeksiyon Paternine Göre HLA ve Non-HLA Antikorlarının Karşılaştırılması

Pages
156–163
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results of XM-ONE cross-matchand flow crossmatch tests were found to be compatible with each other.Conclusion: In conclusion, it was considered that immunosuppressive treatment protocols and surgical complications play important role in rejection attacks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Antibodies against HLA class I and II antigens are important in kidney transplantations because theycause rejections.
📊
Key Findings & Data:In this study it was aimed to detect HLA-and non-HLA antibodies in individualsthat experienced rejection attack.Method: Thirteen patients, who clinically experienced rejection episodes according to the biochemical test resultsafter transplantation, were tested by lymphocyte crossmatch (by using the lymphocytes of their living relateddonors) and non-HLA specific anti-endothelial crossmatch methods.Results: Antibodies specific for Tie-2 receptor positive cells were not detected.
💡
Conclusion & Impact:The results of XM-ONE cross-matchand flow crossmatch tests were found to be compatible with each other.Conclusion: In conclusion, it was considered that immunosuppressive treatment protocols and surgical complications play important role in rejection attacks.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Antibodies against HLA class I and II antigens are important in kidney transplantations because theycause rejections. Not only antibodies against HLA antigens but also those against non-HLA antigenic system play arole in antibody mediated rejections. In this study it was aimed to detect HLA-and non-HLA antibodies in individualsthat experienced rejection attack.Method: Thirteen patients, who clinically experienced rejection episodes according to the biochemical test resultsafter transplantation, were tested by lymphocyte crossmatch (by using the lymphocytes of their living relateddonors) and non-HLA specific anti-endothelial crossmatch methods.Results: Antibodies specific for Tie-2 receptor positive cells were not detected. The results of XM-ONE cross-matchand flow crossmatch tests were found to be compatible with each other.Conclusion: In conclusion, it was considered that immunosuppressive treatment protocols and surgical complications play important role in rejection attacks. Further studies can contributed to determination of graft survival.

Özet

Amaç: HLA Sınıf I ve sınıf II antijenlerine karşı oluşmuş antikorlar böbrek nakillerinde rejeksiyon sebebi oldukları için önemlidirler. Sadece HLA antijenlerine karşı değil non-HLA antijenik sistemlere karşı üretilen antikorlar da antikor aracılı rejeksiyonda rol oynarlar. Bu çalışmada rejeksiyon atağı geçiren kişilerde HLA ve non-HLA antikorlarının belirlenmesi amaçlanmıştır. Yöntem: Transplantasyondan sonra biyokimya test sonuçlarına göre rejeksiyon atağı geçiren 13 hasta lenfosit crossmatch (canlı-akraba donörlerinden alınan lenfositler kullanılmıştır) ve non-HLA spesifik anti-endoteliyal crossmatch yöntemleri ile test edildi. Bulgular: Tie-2 reseptörüne spesifik belirlenmedi. XM-ONE crossmatch ve flow crossmatch test sonuçları birbirileri ile uyumlu bulundu. Sonuç: Sonuç olarak rejeksiyon ataklarında immunsupresif tedavi protokolleri ve cerrahi komplikasyonlar önemli rol oynadığı düşünülmelidir. Gelecekteki çalışmalar greft yaşam ömrünün belirlenmesine katkı sağlayabilir.

🔖

Cite This Article

KOÇYİĞİT, A. Ö., SOYÖZ, M., PİRİM, İ., AYNA, T. K., ÇERÇİ, B. (2022). Comparison of HLA and Non-HLA Antibodies Regarding to Rejection Pattern of the Kidney Transplantation. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 30 - Sayı: 2, 156–163. https://ajindex.com/articles/558085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kaczmarczyk M, Kotfis K, Biernawska J, et al. Effect of recipient sensitization (peak panel reactive antibodies) on 15-year survival after kidney transplantation. Transplant Proc. 2014
  2. 46(8):2699-2702. [CrossRef] 2. Terasaki PI. Humoral theory of transplantation. Am J Transplant. 2003
  3. [CrossRef] 3. Scornik JC. Detection of alloantibodies by flow cytometry: relevance to clinical transplantation. Cytometry. 1995
  4. [CrossRef] 4. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964
  5. [CrossRef] 5. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation. 2003
  6. [CrossRef] 6. Zachary AA, Delaney NL, Lucas DP, Leffell MS. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: I. Evaluation of the GTI QuikID assay and analysis of antibody patterns. Hum Immunol. 2001
  7. [CrossRef] 7. Breimer ME, Rydberg L, Jackson AM et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation. 2009
  8. [CrossRef] 8. Cerilli J, Bay W, Brasile L. The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney grafts. Hum Immunol. 1983
  9. [CrossRef] 9. Kalil J, Guilherme L, Neumann J et al. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc. 1989
  10. Sumitran-Holgersson S. Relevance of MICA and other nonHLA antibodies in clinical transplantation. Curr Opin Immunol. 2008
  11. 20(5):607-13. [CrossRef] 11. Terasaki PI. Deduction of the fraction of immunologic and nonimmunologic failure in cadaver donor transplants. Clinical Transplants. 2003
  12. Jackson AM, Kuperman MB, Montgomery RA. Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. Am J Transplant. 2012
  13. 12(6):1643-9. [CrossRef] 13. Michaels PJ, Fishbein MC, Colvin RB. Humoral rejection of human organ transplants. Seminars in Immunopathol. 2003
  14. 25(2):119-40. [CrossRef] 14. Sigdel TK, Sarwal MM. Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol. 2013
  15. 74(11):1486-90. [CrossRef] 15. Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation. Nature Rev Nephrol. 2016
  16. 12(8):484-95. [CrossRef] 16. Alheim M,